Cardiovascular Risk in Women With PCOS

CITEDBY Reports

  1. Renjiao Zhang, Qi Song, Hongwei Liu, Huai Bai, Yujin Zhang, Qingqing Liu, Linbo Guan, Ping Fan, . Effect of the R92H and A379V genotypes of platelet-activating factor acetylhydrolase on its enzyme activity, oxidative stress and metabolic profile in Chinese women with polycystic ovary syndrome. Lipids in Health and Disease, 2017; 16(1): .
    Crossref
  2. Daiana Cristina Chielli Pedroso, Cristiana Libardi Miranda-Furtado, Gislaine Satyko Kogure, Juliana Meola, Maja Okuka, Celso Silva, Rodrigo T. Calado, Rui Alberto Ferriani, David L. Keefe, Rosana Maria dos Reis, . Inflammatory biomarkers and telomere length in women with polycystic ovary syndrome. Fertility and Sterility, 2015; 103(2): 542.
    Crossref
  3. Signe Frøssing, Malin Nylander, Mubeena Aziz, Sven O. Skouby, Caroline Kistorp, Jens Faber, . Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study. Gynecological Endocrinology, 2017; 33(1): 30.
    Crossref
  4. Lingxia Ha, Yuhua Shi, Junli Zhao, Tao Li, Zi-Jiang Chen, Yang Yu, . Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women. PLOS ONE, 2015; 10(5): e0126505.
    Crossref
  5. F.S. Silva, M.O. Sóter, M.F. Sales, A.L. Candido, F.M. Reis, I.F.O. Silva, M.O. Sousa, C.N. Ferreira, K.B. Gomes, . Estrogen receptor αlpha gene (ESR1) PvuII and XbaI polymorphisms are associated to metabolic and proinflammatory factors in polycystic ovary syndrome. Gene, 2015; 560(1): 44.
    Crossref
  6. S. Gidwani, N. Phelan, J. McGill, A. McGowan, A. O'Connor, I. S. Young, J. Gibney, J. McEneny, . Polycystic ovary syndrome influences the level of serum amyloid A and activity of phospholipid transfer protein in HDL2 and HDL3. Human Reproduction, 2014; 29(7): 1518.
    Crossref
  7. Mehri Jamilian, Fatemeh Foroozanfard, Fereshteh Bahmani, Rezvan Talaee, Mahshid Monavari, Zatollah Asemi, . Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial. Biological Trace Element Research, 2016; 170(2): 271.
    Crossref
  8. Wassim Y. Almawi, Bayan Hubail, Dana Z. Arekat, Suhaila M. Al-Farsi, Shadha K. Al-Kindi, Mona R. Arekat, Naeema Mahmood, Samira Madan, . Leutinizing hormone/choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome. Journal of Assisted Reproduction and Genetics, 2015; 32(4): 607.
    Crossref
  9. Robert Krysiak, Witold Zmuda, Boguslaw Okopien, . The Effect of Ezetimibe on Androgen Production in Hypercholesterolemic Women with Polycystic Ovary Syndrome. Cardiovascular Therapeutics, 2014; 32(5): 219.
    Crossref
  10. Da Eun Lee, Soo Yeon Park, So Yun Park, Sa Ra Lee, Hye Won Chung, Kyungah Jeong, . Clinical and Biochemical Profiles according to Homeostasis Model Assessment-insulin Resistance (HOMA-IR) in Korean Women with Polycystic Ovary Syndrome. Journal of Menopausal Medicine, 2014; 20(3): 104.
    Crossref
  11. M. Szczuko, M. Zapałowska-Chwyć, D. Maciejewska, A. Drozd, A. Starczewski, E. Stachowska, . High glycemic index diet in PCOS patients. The analysis of IGF I and TNF-α pathways in metabolic disorders. Medical Hypotheses, 2016; 96(): 42.
    Crossref
  12. Alice Albu, Serban Radian, Simona Fica, Carmen Gabriela Barbu, . Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients. Endocrine, 2015; 48(2): 696.
    Crossref